Nutriband Inc. (NTRBW)
NTRBW Stock Price Chart
Explore Nutriband Inc. interactive price chart. Choose custom timeframes to analyze NTRBW price movements and trends.
NTRBW Company Profile
Discover essential business fundamentals and corporate details for Nutriband Inc. (NTRBW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 Oct 2021
Employees
3.00
Website
http://nutriband.comCEO
Gareth Sheridan
Description
Nutriband Inc. is a pharmaceutical company dedicated to advancing a diverse pipeline of transdermal drug products. Foremost among its developmental initiatives is an abuse-deterrent fentanyl transdermal system. This innovative patch aims to provide both healthcare providers and patients with an extended-release fentanyl solution for the effective management of chronic pain. Beyond its core transdermal portfolio, Nutriband Inc. also holds a licensing agreement with Rambam Med-Tech Ltd. for the development of RAMBAM Closed System Transfer Devices. Established in 2016, the company maintains its corporate headquarters in Orlando, Florida.
NTRBW Financial Timeline
Browse a chronological timeline of Nutriband Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 30 Sept 2026
Earnings released on 29 Apr 2026
EPS came in at -$0.08 surpassing the estimated -$1.89 by +95.79%, while revenue for the quarter reached $400.71k , missing expectations by -47.62%.
Earnings released on 11 Dec 2025
EPS came in at -$0.32 surpassing the estimated -$2.13 by +84.98%, while revenue for the quarter reached $346.06k , missing expectations by -48.73%.
Earnings released on 9 Sept 2025
EPS came in at -$2.12 matching the estimated -$2.12, while revenue for the quarter reached $622.00k , meeting expectations.
Earnings released on 30 May 2025
EPS came in at -$0.12 matching the estimated -$0.12, while revenue for the quarter reached $667.00k , meeting expectations.
Earnings released on 28 Apr 2025
EPS came in at -$0.50 matching the estimated -$0.50, while revenue for the quarter reached $642.00k , meeting expectations.
Earnings released on 4 Dec 2024
EPS came in at -$0.12 , while revenue for the quarter reached $646.00k .
Earnings released on 3 Sept 2024
EPS came in at -$0.15 falling short of the estimated -$0.05 by -200.00%, while revenue for the quarter reached $442.83k , missing expectations by -34.40%.
Earnings released on 31 May 2024
EPS came in at -$0.21 falling short of the estimated -$0.07 by -200.00%, while revenue for the quarter reached $408.53k , missing expectations by -27.46%.
Earnings released on 1 May 2024
EPS came in at -$0.23 falling short of the estimated -$0.07 by -228.57%, while revenue for the quarter reached $524.61k , missing expectations by -6.85%.
Earnings released on 13 Dec 2023
EPS came in at -$0.22 falling short of the estimated -$0.12 by -83.33%, while revenue for the quarter reached $427.84k , missing expectations by -6.20%.
Earnings released on 8 Sept 2023
EPS came in at -$0.11 falling short of the estimated -$0.08 by -42.60%, while revenue for the quarter reached $655.93k , beating expectations by +37.25%.
Earnings released on 9 Jun 2023
EPS came in at -$0.13 surpassing the estimated -$0.22 by +41.67%, while revenue for the quarter reached $476.93k , beating expectations by +4.65%.
Earnings released on 26 Apr 2023
EPS came in at -$0.21 falling short of the estimated -$0.05 by -320.00%, while revenue for the quarter reached $527.54k , missing expectations by -21.85%.
Earnings released on 5 Dec 2022
EPS came in at -$0.14 falling short of the estimated -$0.07 by -100.00%, while revenue for the quarter reached $620.00k , beating expectations by +10.09%.
Earnings released on 8 Sept 2022
EPS came in at -$0.12 matching the estimated -$0.12, while revenue for the quarter reached $456.12k , beating expectations by +0.01%.
Stock split effective on 15 Aug 2022
Shares were split 7 : 6 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 May 2022
EPS came in at -$0.09 falling short of the estimated -$0.04 by -105.79%, while revenue for the quarter reached $477.92k , beating expectations by +2.78%.
Earnings released on 28 Apr 2022
EPS came in at -$0.55 falling short of the estimated -$0.01 by -6.32k%, while revenue for the quarter reached $491.89k , beating expectations by +25.55%.
Earnings released on 14 Dec 2021
EPS came in at -$0.23 falling short of the estimated -$0.03 by -570.75%, while revenue for the quarter reached $283.04k , beating expectations by +234.96%.
Earnings released on 3 Sept 2021
EPS came in at -$0.08 falling short of the estimated -$0.07 by -11.56%, while revenue for the quarter reached $213.74k , beating expectations by +79.01%.
NTRBW Stock Performance
Access detailed NTRBW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
